Back to Trades
Sell4
Acumen Pharmaceuticals, Inc.
ABOS
Total Value
$7.6K
Net $7.6K sold
Sales
$7.6K
2 transactions
Company Information
- Company Name
- Acumen Pharmaceuticals, Inc.
- Ticker Symbol
- ABOS
- CIK
- 0001576885
Insider Information
- Name
- Zuga Matt
- Role
- CFO & Chief Business Officer
- Location
- NEWTON, MA
Officer
Filing Details
- Filing Date
- Jan 23, 2026
- Transaction Date
- Jan 21, 2026
- Accession Number
- 0001628280-26-003347
- Form Type
- 4
- Net Trading Amount
- -$7.6K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jan 21, 2026 | Common Stock | 2,473 | $1.81 | Sale | $4.5K |
| Jan 22, 2026 | Common Stock | 1,687 | $1.86 | Sale | $3.1K |
Footnotes
- (F1)Represents the number of shares sold by the Reporting Person through an automatic "sell to cover" transaction to satisfy tax withholding obligations in connection with the vesting of restricted stock units pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 30, 2024.
- (F2)The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.7650 to $1.8700. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.